March 24, 2023
Ono Pharmaceutical said on March 23 that it has concluded a collaboration pact with Kawasaki-based Molcure, which owns an AI-driven drug discovery platform, to discover and develop innovative antibody therapeutics directed at multiple targets. The deal will see Molcure work...read more